TL;DR: Coral Genomics is a Y Combinator Summer 2018 startup New clinical tests for managing autoimmune treatments., currently acquired with a team of 5.
New clinical tests for managing autoimmune treatments.
Last verified:
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
Built by LemStudio
Yes. Coral Genomics was funded by Y Combinator in the Summer 2018 batch. New clinical tests for managing autoimmune treatments.
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
Coral Genomics was part of Y Combinator's Summer 2018 batch.
Coral Genomics has a team of 5 people according to Y Combinator's directory.
Coral Genomics is currently listed as Acquired with a team of 5 in Y Combinator's directory.
Loading interactive view…